Marginalized Accessibility to Effective COVID-19 Therapies Further Emphasizes the Need for Ohio House Bill 631
Despite receiving two-doses of the COVID-19 vaccines and a booster shot, Ohio Governor Mike DeWine and First Lady, Fran DeWine, were recently diagnosed with SARS-CoV-2 infections by their personal physician and benefited from the administration of monoclonal anti-bodies that the Food and Drug Administration (FDA) declared unauthorized for use in the United States.
“Wow must be nice to get that treatment. My daughter was denied this treatment. She was very sick. She spent one week in the hospital fighting for her life,” said a commentor in response to the governor’s media release on Friday, April 15 2022.
The sentiment is shared by other Ohioans who have long been denied the right to try effective and potentially life-saving therapeutics to treat SARS-CoV-2, which is why Ohio State Rep. Kris Jordan (R-Ostrander) introduced House Bill 631, otherwise known as the COVID-19 Health Care Professional-Patient Relationship Protection Act.
Among House Bill 631 provisions is that a patient who has been diagnosed with SARS-CoV-2, or its variants, “may use any of the following drugs or therapies, either alone or in combination with other available drugs and therapies: Hydroxychloroquine, Azithromycin, Ivermectin, Budesonide” and “any other drug or therapy that may be proven effective or deemed beneficial by the healthcare provider in consultation with the patient or legally authorized representative.”
If passed into law, House Bill 631 would also ensure that the “health care professional-patient relationship shall be honored and the patient or patient’s legally authorized representative reserves the right to choose the patient’s treatment,” free of any adverse repercussions that may be taken by a department of health, state medical board, health care facility, pharmacy, government entity or official, that attempts to “Reprimand, threaten, or penalize a health care professional for prescribing, administering, or promoting any of the drugs and therapies described” in the Act.
“When you have health bureaucrats going after doctors for prescribing life-saving therapeutics, it hinders the sacred doctor patient relationship and robs individuals of their right to choose their preferred course of treatment,” said Rep. Jordan. “Doctors and patients should be allowed to take medication that they reasonably believe will save their lives or improve their health, without suffering any dire consequences for making a that choice,” he added.
The introduction of House Bill 631 also comes at the heels of the Director of the National Institute of Allergy and Infectious Diseases (NIAID) and the Chief Medical Advisor to the President, Anthony Fauci’s revelation on a PBS NewsHour interview with Judy Woodruff this week that the United States is “out of the pandemic phase” but that the virus will not be eradicated.
Instead of advocating for safe and effective therapeutics considering the virus will continue to persist, Fauci proceeded to tout the experimental vaccine that has shown to be ineffective at preventing the contraction and transmission of SARS-CoV-2 and its variants, as further evidenced by both the Ohio Governor and First Lady’s symptomatic infections of COVID-19, by encouraging the intermittent vaccination of people.
“So, if you’re saying, are we out of the pandemic phase in this country, we are. What we hope to do, I don’t believe – and I have spoken about this widely – we’re not going to eradicate this virus. If we can keep that level very low, and intermittently vaccinate people – and I don’t know how often that would have to be, Judy,” said Fauci.
Continuing to solely advocate for an ineffective, experimental jab that carries significant risks, including the potential tragic loss of life like the case of 17-year-old Ernesto Borrado Ramirez Jr., who developed heart inflammation because of the Pfizer vaccine and died shortly after receiving the second dose, is not only a grave disservice to the people but reminiscent of Fauci’s sabotage of safe and effective off-patent therapeutic treatments for AIDS, as revealed in “The Real Antony Fauci: Bill Gates, Big Pharma and the Global War on Democracy and Public Health,” written By Robert F. Kennedy. Jr.
The fact is that there are effective treatments and therapeutics that frontline doctors across the nation such as Pulmonary and Critical Care Specialist and President of Front-Line Covid-19 Critical Care (FLCCC) Alliance, Dr. Pierre Kory, have been utilizing to effectively treat COVID-19 patients.
The therapeutics listed in House Bill 631, namely ivermectin and hydroxychloroquine, both FDA approved medications that have long been repurposed for off-label diagnosis, are among the treatments that have been effectively utilized by frontline physicians to treat COVID-19 patients and been shown to significantly reduce the viral load and duration of SARS-CoV-2, according to the extensive peer reviewed scientific literature.
For instance, a real-time meta-analysis of 82 studies on ivermectin, which is the lifesaving therapy that merited the 2015 Nobel Prize in Physiology or Medicine award, showed up to a 72% improvement for early treatment and up to 89% success at prophylactically preventing COVID infections.
Additionally, these charts published by FLCCC Alliance reflect the dramatic drop in SARS-CoV-2 cases in countries that included ivermectin in their treatment protocol.
Another peer reviewed study published in Science Direct revealed that ivermectin is an inhibitor of the COVID-19 causative SARS-CoV-2 virus in vitro, showing that a single treatment was able to effect a 5,000-fold reduction in viral load at 48 hours in cell culture.
The robust findings align with the National Library of Medicine report that asserts the following:
“Ivermectin proposes many potential effects to treat a range of diseases, with its antimicrobial, antiviral, and anti-cancer properties as a wonder drug. It is highly effective against many microorganisms including some viruses. In this comprehensive systematic review, antiviral effects of ivermectin are summarized including in vitro and in vivo studies over the past 50 years. Several studies reported antiviral effects of ivermectin on RNA viruses such as Zika, dengue, yellow fever, West Nile… Avian influenza A, Human immunodeficiency virus type 1 and severe acute respiratory syndrome coronavirus 2.”
In other words, since ivermectin plays a role in various biological mechanisms, the wonder drug is an excellent candidate for treating a wide range of microorganisms, including SARS-CoV-2 and other types of single stranded RNA viruses.
Like ivermectin, hydroxychloroquine has also been reported to be effective at significantly reducing the viral load and duration of SARS-CoV-2 among Chinese COVID-19 patients. The study’s result also revealed that “Azithromycin added to hydroxychloroquine was significantly more efficient for virus elimination.”
News reporters disseminating misinformation that contradicts the peer reviewed scientific literature are shamelessly regurgitating the results of a propagated fraudulent study published in the Lancet in mid-2020 that was retracted after suggesting that hydroxychloroquine increased the risk of abnormal heart rhythm and death among COVID-19 patients.
The authenticity of the fraudulent study came under scrutiny after scientists and clinicians raised concerns about the veracity of the data that was obtained from Surgisphere Corporation, a Chicago based company.
Reportedly, the experts “pointed out many red flags in the Lancet paper, including the astonishing number of patients involved and details about their demographics and prescribed dosing that seem implausible.”
The Lancet issued an Expression of Concern “to alert readers to the fact that serious scientific questions” about the data were brought to their attention and that “an independent audit of the provenance and validity of the data has been commissioned by the authors not affiliated with Surgisphere and is ongoing.”
Next month marks two years since the deception and scandal that halted the distribution of the potentially life-saving therapeutic that has otherwise been repurposed for decades, yet no updates on the investigation have been provided by the Lancet.
Nevertheless, studies asserting the effectiveness of Hydroxychloroquine and other therapeutics to treat COVID-19 patients continues to mount, as evidenced by this real-time analysis of 1,716 studies.
Therefore, while Fauci and Vax-A-Million proponent Governor DeWine continue to push for the endless consumption of the multibillion dollar experimental jabs that line the pockets of big pharma and are protected from liability via the Public Readiness and Emergency (PREP) Act because they are a covered countermeasure, House Bill 631 seeks to protect the doctor-patient relationship and facilitate access to safe, low-cost therapeutics proven to be both effective treatments and prophylactics that prevent the contraction of SARS-CoV-2 and its causative variants of COVID-19.
As Rep. Jordan said, “I want to protect the doctor patient relationship to where they don’t have to worry about being punished when they prescribe potentially life-saving treatments.”
To support House Bill 631, please visit this page and participate in the COVID-19 Health Care Professional-Patient Relationship Protection Act Call-To-Action initiated by Children’s Health Defense (CHD) Ohio Chapter.